Abstract
Multidisciplinary approach to safety of antithrombotic therapy used in clinical practice is reported. Such complications of antithrombotic therapy as gastrointestinal tract (GIT) erosion/ulceration and gastrointestinal bleeding are discussed in detail. The modern pathogenetically substantiated methods of gastric mucosa protection based on the use of rebamipide, the GIT mucosal protector agent with proven efficacy, are proposed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
